Inventisbio Co., Ltd
Clinical trials sponsored by Inventisbio Co., Ltd, explained in plain language.
-
New psoriasis drug shows promise in Mid-Stage trial
Disease control CompletedThis study tested whether an investigational drug called D-2570 is effective and safe for treating moderate-to-severe plaque psoriasis. It involved 161 participants who were randomly assigned to receive either D-2570 or a placebo (a dummy treatment) for 12 weeks. The main goal wa…
Phase: PHASE2 • Sponsor: InventisBio Co., Ltd • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC
-
First test of new drug in healthy volunteers
Knowledge-focused CompletedThis was an early safety study to see how healthy people's bodies react to and process a new tablet called D-2570. One hundred healthy volunteers took either the drug or a placebo (a dummy pill) in different doses, and some took it with or without food. Researchers closely monito…
Phase: PHASE1 • Sponsor: InventisBio Co., Ltd • Aim: Knowledge-focused
Last updated Apr 01, 2026 21:41 UTC